Cargando…

A Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival in Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disorder characterized by its heterogeneous clinical evolution. Despite the discovery of the most frequent cytogenomic drivers of disease during the last decade, new efforts are needed in order to improve prognostication. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosquera Orgueira, Adrián, Antelo Rodríguez, Beatriz, Díaz Arias, José Ángel, Díaz Varela, Nicolás, Bello López, José Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885206/ https://www.ncbi.nlm.nih.gov/pubmed/31827514 http://dx.doi.org/10.1155/2019/9453539

Ejemplares similares

Identification of new putative driver mutations and predictors of disease evolution in chronic lymphocytic leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2019)

Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2020)

New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2019)

Time to Treatment Prediction in Chronic Lymphocytic Leukemia Based on New Transcriptional Patterns
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2019)

The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2019)

Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC-50 Model
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Corrigendum: Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2023)

Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2021)

P967: A MACHINE LEARNING MODEL FOR RISK PREDICTION IN MULTIPLE MYELOMA PROGRESSING AFTER THE FIRST LINE OF THERAPY
por: Mosquera-Orgueira, Adrian, et al.
Publicado: (2023)

Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2021)

Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Correction: Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2020)

Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2022)

PB2384: EVALUATION OF NEW MACHINE LEARNING SYSTEMS FOR PROGNOSTICATION BASED ON GENE EXPRESSION SIGNATURES IN MANTLE CELL AND PERIPHERAL T CELL LYMPHOMAS
por: Mosquera-Orgueira, Adrian, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis
por: Gómez-Llobell, Marina, et al.
Publicado: (2022)

PB2624: CLINICAL WHOLE EXOM SEQUENCING FOR CONGENITAL PLATELET DISORDERS: ONE SINGLE CENTER EXPERIENCE
por: Piñeiro, Victor Portela, et al.
Publicado: (2023)

An Integrative Analysis of Meningioma Tumors Reveals the Determinant Genes and Pathways of Malignant Transformation
por: Iglesias Gómez, José Carlos, et al.
Publicado: (2014)

Hidden among the crowd: differential DNA methylation-expression correlations in cancer occur at important oncogenic pathways
por: Mosquera Orgueira, Adrián
Publicado: (2015)

Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2021)

Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2021)

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2023)

P1234: A PROGNOSTIC MODEL BASED ON GENE EXPRESSION PARAMETERS PREDICTS A BETTER RESPONSE TO BORTEZOMIB-CONTAINING IMMUNOCHEMOTHERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA
por: Mosquera-Orgueira, Adrian, et al.
Publicado: (2023)

Developing Molecular Signatures for Chronic Lymphocytic Leukemia
por: Cornet, Edouard, et al.
Publicado: (2015)

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
por: Wang, Yucai, et al.
Publicado: (2021)

APOBEC3 signature mutations in chronic lymphocytic leukemia
por: Rebhandl, S, et al.
Publicado: (2014)

P1047: AIPSS-MF MACHINE LEARNING MODEL AS USEFUL PROGNOSTIC SCORE COMPARED TO IPSS IN THE SETTING OF MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB
por: Duminuco, Andrea, et al.
Publicado: (2023)

AIPSS‐MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib
por: Duminuco, Andrea, et al.
Publicado: (2023)

Cytoplasmic crystal inclusions in lymphocytes of chronic lymphocytic leukemia
por: Villuendas Vázquez, Òscar, et al.
Publicado: (2020)

Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
por: Landeira-Viñuela, Alicia, et al.
Publicado: (2022)

Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively
por: Moreno, Carol, et al.
Publicado: (2021)

The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas
por: Tomacinschii, Victor, et al.
Publicado: (2023)

Lenalidomide and Chronic Lymphocytic Leukemia
por: González-Rodríguez, Ana Pilar, et al.
Publicado: (2013)

Clustering of Expression Data in Chronic Lymphocytic Leukemia Reveals New Molecular Subdivisions
por: Yepes, Sally, et al.
Publicado: (2015)

Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia
por: Chocholska, Sylwia, et al.
Publicado: (2023)

Leukemia Cutis As the Initial Manifestation of Chronic Lymphocytic Leukemia Progression
por: Pedreira-García, Wilfredo M, et al.
Publicado: (2022)

Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution
por: Landeira-Viñuela, Alicia, et al.
Publicado: (2023)

Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia
por: Hurtado, A M, et al.
Publicado: (2015)

Chronic lymphocytic leukemia with unusual cytoplasmic anomalies
por: Athanase, Nicolas
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qi3m7bj5c15ku153htbgt3cfou